advent
recombin
dna
technolog
develop
infecti
cdna
clone
rna
virus
revers
genet
technolog
revolution
virus
studi
genet
manipul
fulllength
cdna
clone
becom
especi
import
wide
use
tool
studi
biolog
pathogenesi
virul
determin
posit
neg
strand
rna
virus
first
fulllength
infecti
cdna
clone
equin
arter
viru
eav
develop
also
first
fulllength
infecti
cdna
clone
construct
member
order
nidoviral
clone
extens
use
character
molecular
biolog
eav
nidovirus
object
review
summar
character
virul
attenu
phenotyp
recombin
virus
deriv
sever
infecti
cdna
clone
eav
hors
well
applic
character
molecular
basi
viral
neutral
persist
cellular
tropism
hors
late
dr
william
h
mccollum
colleagu
univers
kentucki
fig
repeat
serial
passag
origin
bucyru
viru
natur
host
markedli
enhanc
virul
hors
passag
hors
passag
strain
passag
viru
consist
caus
sever
clinic
diseas
frequent
death
hors
fatal
rate
socal
velogen
virul
bucyru
eav
follow
experiment
inocul
maclachlan
et
al
mccollum
timoney
follow
creation
continu
cell
line
viru
pleural
fluid
archiv
late
dr
roger
doll
william
h
mccollum
passag
rabbit
kidney
cell
aliquot
passag
bucyru
strain
eav
deposit
american
type
cultur
collect
atcc
manassa
va
catalog
number
significantli
mani
histor
refer
use
put
bucyru
strain
eav
fact
includ
origin
viru
associ
eva
outbreak
unfortun
origin
bucyru
viru
subsequ
hors
passag
strain
hors
passag
lost
due
freezer
failur
archiv
pleural
fluid
hors
passag
also
identifi
eav
virul
bucyru
strain
vb
limit
passag
deriv
viru
atcc
remain
fulllength
genom
sequenc
analysi
two
virus
atcc
laboratori
shown
ident
caus
fatal
eva
major
experiment
inocul
hors
maclachlan
et
al
mccollum
timoney
thu
pleural
fluid
origin
hors
passag
atcc
design
vb
strain
eav
importantli
howev
vb
artifact
caus
sever
often
fatal
diseas
hors
wherea
field
strain
eav
typic
caus
fatal
diseas
adult
hors
balasuriya
et
al
refer
therein
balasuriya
maclachlan
mccollum
timoney
inde
mani
field
strain
caus
mild
diseas
even
subclin
infect
balasuriya
et
al
balasuriya
et
al
balasuriya
et
al
balasuriya
maclachlan
go
et
al
patton
et
al
pronost
et
al
vairo
et
al
zhang
et
al
zhang
et
al
dr
doll
mccollum
distribut
vb
strain
eav
variou
laboratori
europ
elsewher
late
thereaft
origin
vb
viru
extens
passag
vitro
sometim
plaqu
purifi
differ
laboratori
extens
cell
cultur
passag
essenti
laboratoryadapt
eav
strain
often
misleadingli
design
bucyru
eav
without
refer
passag
histori
simpli
state
highli
cell
cultur
passag
laboratori
deriv
vb
strain
eav
distinct
genet
sequenc
phenotyp
properti
final
although
vb
strain
eav
somewhat
laboratori
aberr
due
sequenti
experiment
passag
hors
viru
use
studi
virul
determin
eav
mechan
viral
pathogenesi
furthermor
current
modifi
live
viru
mlv
live
attenu
eav
vaccin
arvac
zoeti
kalamazoo
mi
usa
use
immun
hors
unit
state
origin
produc
extens
cell
cultur
passag
eav
vb
laboratori
strain
eav
origin
infecti
cdna
clone
deriv
van
dinten
et
al
fig
long
known
positivesens
viral
rna
infecti
gener
progeni
viru
follow
introduct
cell
alexand
et
al
b
first
demonstr
infect
polioviru
rna
hela
cell
subsequ
racaniello
baltimor
b
develop
first
infecti
cdna
clone
polioviru
clone
fulllength
rna
genom
bacteri
plasmid
vector
advent
revers
transcript
polymeras
chain
reaction
rtpcr
technolog
along
recombin
dna
techniqu
expedit
develop
infecti
cdna
clone
rna
virus
boyer
haenni
mulli
faloona
subsequ
shown
numer
viru
system
vitro
transcript
cdna
clone
instanc
cdna
initi
complet
product
infecti
cycl
suscept
mammalian
cell
result
genet
manipul
revers
genet
fulllength
cdna
clone
becom
import
tool
studi
biolog
pathogenesi
virul
determin
posit
neg
strand
rna
virus
revers
genet
strategi
especi
use
identif
function
character
specif
viral
gene
demonstr
phenotyp
effect
consequ
introduc
defin
nucleotid
chang
gene
interest
eav
includ
within
order
nidoviral
prototyp
viru
genu
arteriviru
famili
arterivirida
fig
similar
posit
strand
rna
virus
genom
arterivirus
infecti
cell
meulenberg
et
al
van
der
zeijst
horzinek
first
fulllength
infecti
cdna
clone
eav
develop
clone
twelv
fragment
cdna
librari
span
entir
genom
highli
cell
cultur
adapt
laboratori
strain
eav
downstream
rna
polymeras
promot
plasmid
vector
peav
genbank
access
number
fig
van
dinten
et
al
also
first
fulllength
infecti
cdna
clone
construct
member
order
nidoviral
second
infecti
cdna
clone
similar
highli
cell
cultureadapt
laboratori
strain
eav
describ
soon
thereaft
de
vri
et
al
de
vri
et
al
glaser
et
al
recent
describ
develop
two
infecti
cdna
clone
eav
first
highlyvirul
horseadapt
vb
strain
eav
peavrvb
balasuriya
et
al
mlv
vaccin
strain
eav
arvac
zoeti
kalamazoo
mi
usa
peavrmlv
origin
develop
extend
cell
cultur
passag
vb
viru
eric
snijder
colleagu
leiden
univers
netherland
perform
pioneer
work
use
peav
infecti
cdna
clone
character
molecular
biolog
eav
nidovirus
snijder
et
al
snijder
et
al
snijder
spann
snijder
refer
therein
snijder
kikkert
refer
therein
specif
use
infecti
clone
better
character
eav
replic
includ
process
viral
nonstructur
protein
nsp
balasuriya
et
al
snijder
snijder
snijder
spann
van
aken
et
al
b
van
dinten
et
al
mechan
subgenom
mrna
sgmrna
transcript
tijm
et
al
tijm
et
al
tijm
snijder
van
den
born
et
al
van
dinten
et
al
van
marl
et
al
b
role
viral
replic
complex
snijder
molenkamp
et
al
pasternak
et
al
siddel
et
al
smit
et
al
small
size
eav
genom
compar
coronaand
torovirus
made
ideal
model
system
studi
replic
strategi
nidovirus
smit
et
al
work
extens
review
previous
snijder
spann
refer
therein
snijder
refer
therein
thu
object
articl
review
recent
work
use
three
infecti
cdna
clone
eav
peav
peavrvb
peavrmlv
ancestr
relat
parent
vb
strain
eav
differ
significantli
virul
phenotyp
fig
specif
review
focus
character
virul
phenotyp
recombin
virus
deriv
infecti
cdna
clone
eav
eav
eav
rvb
eav
rmlv
hors
balasuriya
et
al
balasuriya
et
al
go
et
al
well
applic
character
molecular
determin
eav
neutral
persist
protect
host
immun
virul
phenotyp
recombin
virus
deriv
peavrvb
peav
infecti
cdna
clone
eav
eav
rvb
eav
respect
character
experiment
inocul
hors
balasuriya
et
al
balasuriya
et
al
go
et
al
tabl
hors
inocul
rvb
develop
sever
clinic
sign
eva
includ
high
fever
mark
lymphopenia
petechi
ecchymot
hemorrhag
oral
mucou
membran
serou
nasal
discharg
supraorbit
limb
edema
variabl
sever
skin
erupt
hive
hors
develop
high
titer
viremia
signific
viru
shed
nasal
secret
eav
isol
day
postinfect
dpi
buffi
coat
dpi
plasma
nasal
shed
detect
dpi
viru
clearanc
coincid
appear
neutral
antibodi
serum
howev
contrast
result
experiment
infect
origin
vb
strain
viru
deriv
rvb
infecti
clone
caus
fatal
diseas
van
dinten
et
al
pna
eavrvb
balasuriya
et
al
jgv
tabl
data
strongli
suggest
major
virul
determin
lead
fulmin
eva
hors
character
dissemin
intravascular
coagulopathi
death
local
one
key
amino
acid
residu
locat
glyasp
asnser
aspgli
valala
serci
aspasn
amino
acid
chang
inadvert
introduc
clone
process
clearli
signific
impact
attenu
virul
phenotyp
parent
vb
strain
eav
also
previous
evalu
virul
phenotyp
recombin
viru
deriv
peav
infecti
cdna
clone
eav
experiment
inocul
two
stallion
balasuriya
et
al
neither
stallion
develop
signific
clinic
manifest
eva
rather
mild
transient
fever
mild
moder
lymphopenia
tabl
viru
isol
transient
nasal
swab
mononuclear
cell
collect
stallion
viru
also
isol
semen
one
stallion
dpi
neither
stallion
becam
persist
infect
eav
data
confirm
recombin
eav
viru
highli
attenu
compar
vb
recombin
counterpart
eav
rvb
importantli
although
design
prototyp
strain
eav
eav
laboratori
variant
deriv
extens
cell
cultur
passag
vb
well
clone
end
point
dilut
plaqu
purif
african
green
monkey
cell
vero
cell
see
fig
basi
compar
sequenc
analysi
serin
proteas
sp
locat
viral
replicas
respect
nest
set
mrna
found
infect
cell
depict
genom
ident
viral
genom
sgmrna
use
express
structur
protein
gene
locat
proxim
quarter
genom
light
blue
box
end
sgmrna
repres
common
leader
sequenc
deriv
end
genom
except
bicistron
sgmrna
sgmrna
function
monocistron
translat
protein
sgmrna
e
protein
protein
leaki
scan
proxim
end
sgmrna
firth
et
al
snijder
et
al
orf
locat
end
genom
translat
two
polyprotein
process
nonstructur
protein
three
viral
proteas
nsp
b
eav
particl
consist
nucleocapsid
n
seven
envelop
protein
includ
two
major
envelop
protein
form
dimer
three
minor
envelop
glycoprotein
form
trimer
two
minor
envelop
protein
e
protein
adapt
balasuriya
et
al
permiss
highli
cell
cultur
adapt
laboratori
strain
eav
use
gener
genom
cdna
librari
use
construct
origin
infecti
cdna
clone
eav
balasuriya
et
al
van
dinten
et
al
probabl
plaqu
purif
cell
cultur
propag
origin
viru
subject
genet
bottleneck
led
select
attenu
variant
compar
nucleotid
amino
acid
sequenc
analysi
eav
origin
vb
strain
identifi
amino
acid
chang
nsp
tabl
fig
two
amino
acid
chang
common
eav
rvb
eav
appear
signific
effect
attenu
two
recombin
virus
furthermor
substitut
protein
eav
led
loss
glycosyl
site
might
also
contribut
attenu
viru
lentogenicno
clinic
sign
hors
develop
immun
eav
mccollum
et
al
lentogenicno
clinic
sign
horizont
transmiss
inocul
hors
intramuscular
administrationhors
develop
protect
immun
transmit
viru
contact
anim
intranas
inoculationdid
immun
effect
harri
mccollum
mckinnon
et
al
timoney
et
al
timoney
et
al
h
hors
primari
hors
kidney
cell
primari
rabbit
kidney
cell
passag
ed
dermi
cell
atcc
hors
passag
b
viru
identifi
cell
type
follow
number
passag
particular
cell
type
eav
vb
serial
passag
time
respect
primari
hors
kidney
cell
eav
vb
serial
passag
primari
hors
kidney
cell
time
primari
rabbit
kidney
cell
time
equin
dermi
cell
line
time
advent
cell
cultur
system
vb
strain
eav
serial
passag
primari
equin
kidney
hk
primari
rabbit
kidney
rk
equin
dermal
ed
atcc
cell
attenu
viru
creat
mlv
vaccin
arvac
fig
virus
differ
level
cell
cultur
passag
inocul
previous
hors
character
virul
phenotyp
tabl
doll
et
al
harri
mccollum
mccollum
mccollum
et
al
mccollum
et
al
b
mccollum
timoney
mckinnon
et
al
summerslawy
et
al
timoney
timoney
et
al
zhang
et
al
virus
span
entir
spectrum
attenu
highli
virul
horseadapt
vb
strain
eav
complet
attenu
mlv
arvac
vaccin
deriv
doll
et
al
harri
mccollum
mccollum
mccollum
et
al
mccollum
et
al
b
mccollum
timoney
mckinnon
et
al
timoney
et
al
compar
whole
genom
sequenc
analysi
virus
differ
level
attenu
includ
vb
moder
virul
mesogen
two
avirul
lentogen
arvac
vaccin
strain
identifi
limit
number
potenti
attenu
mutat
tabl
interestingli
none
differ
locat
either
utr
rather
locat
gene
encod
variou
structur
nonstructur
protein
follow
passag
hk
cell
viru
moder
virul
mesogen
phenotyp
hors
compar
amino
acid
sequenc
analysi
identifi
amino
acid
chang
compar
vb
strain
seven
amino
acid
chang
nsp
tabl
summari
comparison
virul
phenotyp
hors
sequenc
vb
virus
identifi
amino
acid
substitut
individu
collect
appear
respons
attenu
viru
includ
six
amino
acid
substitut
replicas
protein
nsp
amino
acid
substitut
structur
protein
protein
eav
tabl
interestingli
amino
acid
substitut
acquir
sequenti
cell
cultur
passag
eav
primari
hors
kidney
viru
strain
ident
suggest
common
amino
acid
chang
play
import
role
attenu
virul
vb
viru
sequenti
cell
cultur
passag
attenu
virus
amino
acid
substitut
attenu
vb
strain
eav
mesogen
viru
involv
singl
amino
acid
chang
result
loss
glycosyl
site
posit
protein
substitut
conserv
among
cell
cultur
adapt
virus
variabl
retent
glycosyl
site
posit
protein
among
field
strain
eav
suggest
residu
might
play
central
role
eav
virul
pathogenesi
balasuriya
et
al
balasuriya
et
al
balasuriya
et
al
balasuriya
et
al
zhang
et
al
zhang
et
al
similarli
loss
glycosyl
site
equival
ldv
protein
alter
virul
cellular
tropism
viru
chen
et
al
plagemann
plagemann
et
al
c
moreov
amino
acid
substitut
protein
locat
three
b
c
four
major
neutral
site
balasuriya
et
al
refer
therein
unequivoc
determin
signific
individu
nucleotid
amino
acid
substitut
determin
prospect
studi
use
revers
genet
manipul
infecti
cdna
clone
see
confirm
signific
amino
acid
substitut
identifi
compar
sequenc
analysi
three
nsp
four
structur
protein
attenu
introduc
substitut
virul
infecti
cdna
clone
peavrvb
deriv
vb
strain
zhang
et
al
sitedirect
mutagenesi
use
individu
introduc
four
amino
acid
substitut
nsp
peavrvb
infecti
clone
new
recombin
viru
identifi
rvbsvacc
ten
amino
acid
substitut
contain
structur
protein
protein
viru
introduc
swap
viru
entireti
peavrvb
clone
chimer
viru
tabl
hors
inocul
chimer
viru
develop
mild
serou
nasal
discharg
wherea
hors
inocul
rvbsvacc
develop
typic
clinic
sign
eva
confirm
viru
less
attenu
tabl
sinc
recombin
virus
share
backbon
virul
peavrvb
infecti
clone
virul
phenotyp
rvbsvacc
virus
also
compar
virul
parent
rvb
viru
averag
bodi
temperatur
rvbsinocul
hors
significantli
higher
hors
inocul
either
rvbsvacc
virus
wherea
nasal
viru
shed
viremia
similar
rvbsand
hors
nasal
shed
viru
viremia
sinocul
hors
significantli
lower
hors
inocul
either
rvbsor
rvbsvacc
virus
summari
viru
substanti
reduc
virul
hors
compar
parent
rvb
strain
rvbsvacc
viru
caus
subclin
infect
taken
togeth
data
suggest
amino
acid
chang
either
replicas
structur
protein
led
attenu
recombin
viru
multipl
substitut
structur
protein
attenu
recombin
viru
substitut
replicas
protein
signific
numer
noncod
tabl
compar
amino
acid
sequenc
analysi
nonstructur
protein
vb
eav
two
recombin
virus
eav
rvb
eav
three
cell
cultur
passag
eav
strain
arvac
mlv
vaccin
amino
acid
chang
occur
critic
amino
acid
chang
identifi
bold
chang
testedconfirm
revers
genet
major
amino
acid
chang
identifi
color
amino
acid
substitut
compar
parent
eav
vb
b
pheleu
phe
leu
mutat
occur
cell
cultur
passag
vb
viru
directli
evalu
revers
genet
produc
current
commerci
mlv
vaccin
eav
viru
passag
time
hk
cell
follow
respect
passag
rk
ed
cell
addit
cell
cultur
passag
fix
amino
acid
substitut
present
viru
togeth
addit
amino
acid
substitut
compar
includ
nsp
includ
aa
insert
structur
protein
zhang
et
al
howev
numer
addit
amino
acid
substitut
accumul
cell
cultur
passag
arvac
seed
viru
alter
attenu
phenotyp
viru
significantli
viru
alreadi
fulli
attenu
hk
passag
mccollum
mccollum
et
al
howev
extens
addit
cell
cultur
passag
alter
key
neutral
epitop
tabl
compar
amino
acid
sequenc
analysi
structur
protien
vb
eav
two
recombin
virus
eav
rvb
eav
three
cell
cultur
passag
eav
strain
arvac
mlv
vaccin
amino
acid
chang
occur
critic
amino
acid
chang
identifi
bold
chang
testedconfirm
revers
genet
major
amino
acid
chang
identifi
color
amino
acid
substitut
compar
parent
eav
vb
b
arvac
mlv
vaccin
strain
span
nucleotid
amino
acid
length
locat
protein
significantli
chang
neutral
phenotyp
mlv
vaccin
viru
see
balasuriya
et
al
balasuriya
et
al
balasuriya
maclachlan
zhang
et
al
previou
studi
shown
antibodi
gener
hors
polyclon
equin
antisera
mlv
vaccin
strain
neutral
field
strain
eav
effect
equin
antisera
gener
vb
strain
balasuriya
et
balasuriya
et
al
balasuriya
et
al
zhang
et
al
thu
excess
cell
cultur
passag
perhap
overli
attenu
mlv
vaccin
viru
potenti
compromis
protect
efficaci
taken
togeth
compar
amino
acid
sequenc
data
analysi
eav
strain
differ
virul
hors
mlv
vaccin
strain
confirm
virul
determin
eav
may
locat
gene
encod
nonstructur
contain
papainlikecystein
proteas
domain
play
major
role
viru
replic
sgmrna
synthesi
viru
product
coordin
viral
replic
cycl
contain
papainlik
proteas
domain
possess
deubiquitin
enzym
activ
antagon
host
innat
immun
respons
contain
rdrp
domain
direct
viral
rna
synthesi
conjunct
viral
cellular
protein
possibl
contain
predict
zincbind
domain
zbd
nterminu
nucleosid
triphosphatebindinghelicas
hel
motif
ctermin
domain
den
boon
et
al
minor
protein
major
envelop
protein
tabl
fig
interestingli
virus
differ
cell
cultur
passag
histori
share
multipl
common
amino
acid
substitut
confirm
like
import
determin
virul
phenotyp
eav
thu
appear
attenu
eav
complex
process
potenti
involv
varieti
structur
nonstructur
viral
protein
perhap
interact
differ
protein
furthermor
studi
also
identifi
sever
lethal
amino
acid
substitut
caus
vitro
transcrib
rna
noninfecti
genom
replic
infecti
progeni
viru
product
follow
transfect
mammalian
cell
includ
zhang
et
al
balasuriya
et
al
van
dinten
et
al
substitut
locat
cytoplasm
tail
clear
mutat
advers
affect
viru
replic
arginin
substitut
posit
affect
cleavag
made
vitro
transcrib
ivt
rna
noninfecti
follow
transfect
substitut
locat
zbd
may
affect
multipl
function
specif
viral
rna
replic
sgmrna
transcript
biogenesi
may
lead
noninfecti
rna
result
nonviabl
virus
stallion
infect
eav
subsequ
becom
persist
infect
carrier
continu
shed
viru
semen
timoney
mccollum
persist
infect
stallion
princip
reservoir
eav
respons
perpetu
dissemin
eav
equin
popul
maclachlan
timoney
mccollum
carrier
stallion
also
signific
natur
sourc
genet
phenotyp
divers
eav
balasuriya
et
al
balasuriya
et
al
hedg
et
al
howev
viral
factor
involv
establish
mainten
eav
persist
stallion
well
character
identifi
viral
protein
involv
establish
eav
persist
develop
vitro
model
helah
passag
cell
zhang
et
al
wherea
origin
vb
viru
establish
persist
infect
helal
cell
compar
nucleotid
sequenc
analysi
identifi
nucleotid
differ
vb
virus
nucleotid
differ
identifi
utr
orf
approxim
nucleotid
chang
silent
amino
acid
differ
two
virus
includ
four
replicas
structur
protein
e
tabl
role
amino
acid
chang
establish
persist
eav
infect
vitro
evalu
prospect
studi
use
revers
genet
technolog
recombin
viru
ident
sequenc
rvb
viru
except
four
amino
acid
substitut
replicas
polyprotein
unabl
establish
persist
infect
helal
cell
line
fig
wherea
recombin
viru
carri
replicas
gene
parent
rvb
structur
protein
gene
viru
establish
persist
infect
helal
cell
line
clearli
indic
chang
structur
protein
e
replicas
respons
establish
persist
infect
helal
cell
line
viru
determin
recombin
virus
substitut
individu
structur
protein
unabl
establish
persist
infect
helal
cell
wherea
combin
substitut
e
protein
togeth
singl
point
mutat
protein
creat
virus
abl
establish
persist
infect
helal
cell
fig
summari
revers
genet
studi
clearli
show
substitut
structur
protein
rather
replicas
respons
establish
persist
infect
helal
cell
viru
unlik
virul
determin
eav
e
minor
envelop
protein
appear
play
import
role
establish
persist
infect
mammalian
cell
contrast
amino
acid
substitut
unglycosyl
envelop
protein
suggest
protein
role
establish
persist
eav
infect
mammalian
cell
recent
studi
laboratori
shown
vb
viru
infect
equin
endotheli
cell
monocyt
lung
macrophag
also
small
subpopul
cell
studi
evalu
suscept
equin
peripher
blood
mononuclear
cell
pbmc
infect
virul
vb
attenu
mlv
strain
eav
dual
fluoresc
antibodi
stain
pbmc
cultur
perform
use
panel
leukocyt
differenti
antigenspecif
monoclon
antibodi
mab
specif
pan
lymphocyt
helper
lymphocyt
cytotox
lymphocyt
monocyt
well
mab
specif
eav
data
suggest
major
lymphocyt
infect
vb
viru
lymphocyt
rather
lymphocyt
furthermor
contrast
vb
viru
mlv
viru
fail
infect
lymphocyt
investig
whether
monocyt
equal
suscept
infect
vb
mlv
virus
doublelabel
flow
cytometr
analysi
show
monocyt
could
infect
viru
strain
howev
mean
percentag
cell
infect
mlv
viru
significantli
lower
remain
near
lower
limit
detect
compar
detect
vb
virusinfect
cultur
equin
monocyt
find
confirm
lymphocyt
also
monocyt
differ
suscept
infect
vb
mlv
strain
eav
taken
togeth
data
clearli
suggest
vb
mlv
vaccin
strain
eav
differ
abil
infect
pbmc
therefor
use
two
infecti
cdna
clone
eav
rvb
eav
rmlv
well
five
chimer
virus
zhang
et
al
rvbsmlv
rmlvvb
rmlvvb
rmlvvb
fig
infect
ex
vivo
prepar
equin
pbmc
identifi
viral
protein
involv
cellular
tropism
chimer
viru
contain
structur
protein
viru
fulli
attenu
hors
compar
vb
viru
rvb
backbon
infect
significantli
fewer
lymphocyt
compar
rvb
viru
contrast
percentag
monocyt
infect
two
virus
similar
indic
tropism
strain
chang
lymphocyt
monocyt
follow
passag
hk
cell
suscept
lymphocyt
monocyt
infect
rvbsmlv
rmlvvb
virus
rvbsmlv
infect
lymphocyt
replic
monocyt
low
level
ident
occur
follow
infect
rmlv
viru
contrast
rmlvvb
viru
infect
replic
lymphocyt
monocyt
similar
rvb
viru
result
strongli
suggest
structur
protein
vb
viru
respons
determin
tropism
lymphocyt
monocyt
furthermor
comparison
dualcolor
flow
cytometr
analysi
pbmc
infect
rvbsmlv
show
signific
differ
monocyt
infect
indic
amino
acid
substitut
occur
cell
cultur
passag
viru
may
contribut
chang
monocyt
tropism
summari
data
suggest
viral
tropism
lymphocyt
monocyt
alter
amino
acid
chang
envelop
protein
eav
tabl
evalu
role
minor
major
envelop
protein
cellular
tropism
eav
addit
recombin
virus
rmlvvb
rmlvvb
gener
use
rmlv
viral
backbon
rmlvvb
viru
genom
sequenc
ident
rmlv
viru
except
orf
encod
e
minor
envelop
protein
replac
correspond
region
rvb
viru
orf
encod
major
envelop
protein
recombin
rmlvvb
viru
substitut
correspond
gene
rvb
rmlv
backbon
unexpectedli
neither
rmlvvb
rmlvvb
chimera
infect
equin
lymphocyt
fig
comparison
cultur
monocyt
show
wherea
percentag
cell
infect
rmlvvb
viru
similar
rmlv
rvbsmlv
virus
infect
rate
rmlvvb
viru
significantli
lower
fig
panel
n
l
respect
therefor
higher
rel
fluoresc
intens
valu
observ
monocyt
infect
rmlvvb
fig
panel
n
compar
rmlvvb
fig
panel
l
suggest
protein
sequenc
may
play
greater
role
e
facilit
monocyt
infect
although
major
minor
envelop
glycoprotein
appear
import
determin
monocyt
tropism
summari
data
suggest
differ
cellular
tropism
virul
phenotyp
vb
mlv
strain
eav
associ
collect
interact
major
minor
envelop
protein
furthermor
studi
also
demonstr
lymphocyt
tropism
primarili
determin
specif
amino
acid
residu
envelop
protein
minor
envelop
protein
hors
eav
replic
endotheli
cell
blood
mononuclear
cell
select
epitheli
cell
myocyt
balasuriya
snijder
del
piero
maclachlan
et
al
similarli
eav
replic
varieti
primari
cell
cultur
includ
equin
pulmonari
arteri
endotheli
hedg
et
al
hors
kidney
rabbit
kidney
hamster
kidney
cell
number
continu
cell
line
includ
babi
hamster
kidney
hyllseth
maess
et
al
rabbit
african
green
monkey
kidney
vero
konishi
et
al
radwan
burger
hamster
lung
hmlu
konishi
et
al
cell
distinct
contrast
prrsv
replic
limit
number
cell
type
includ
primari
porcin
alveolar
macrophag
pam
african
green
monkey
cell
line
deriv
van
breedam
et
al
recent
viral
envelop
protein
involv
viru
attach
entri
eav
prrsv
poorli
character
da
et
al
tian
et
al
dobb
et
al
demonstr
recombin
chimer
strain
eav
base
eav
backbon
express
ectodomain
prrsv
iafklop
strain
pirzadeh
et
al
alter
cellular
tropism
recent
use
prmlvb
infecti
cdna
clone
character
role
two
major
envelop
protein
cellular
tropism
eav
specif
prmlvb
infecti
cdna
clone
use
backbon
gener
panel
recombin
chimer
virus
replac
ntermin
ectodomain
eav
protein
strain
north
american
prrsv
ntermin
ectodomain
aa
eav
replac
prrsv
ectodomain
aa
gener
construct
ntermin
ectodomain
aa
eav
protein
replac
prrsv
protein
ntermin
ectodomain
aa
gener
mecto
construct
ntermin
ectodomain
eav
replac
prrsv
ntermin
ectodomain
gener
mecto
construct
three
recombin
chimer
virus
genbank
access
number
infect
eav
suscept
cell
line
pam
cell
confirm
unambigu
ectodomain
major
determin
cellular
tropism
consist
recent
find
minor
envelop
protein
critic
protein
mediat
cellular
tropism
prrsv
tian
et
al
major
neutral
determin
eav
map
major
envelop
glycoprotein
encod
balasuriya
et
al
balasuriya
et
al
balasuriya
et
al
balasuriya
et
al
deregt
et
al
chirnsid
et
al
glaser
et
al
weiland
et
al
compar
phenotyp
character
field
neutralizationresist
variant
escap
mutant
em
strain
tabl
amino
acid
substitut
eav
rvb
viru
highli
cell
cultur
passag
eav
arvac
mlv
strain
critic
amino
acid
chang
identifi
bold
chang
testedconfirm
revers
genet
major
amino
acid
chang
identifi
color
amino
acid
substitut
number
accord
rvb
genbank
access
number
b
arvac
mlv
vaccin
strain
span
nucleotid
amino
acid
length
eav
use
neutral
mab
eav
strainspecif
polyclon
equin
antisera
show
antigen
variat
region
protein
princip
respons
differ
neutral
phenotyp
variou
field
strain
eav
genotyp
phenotyp
character
em
field
strain
eav
identifi
conform
linear
neutral
determin
includ
amino
acid
site
site
b
site
c
site
protein
balasuriya
et
al
zhang
et
al
subsequ
revers
genet
manipul
infecti
cdna
clone
character
neutral
determin
envelop
glycoprotein
balasuriya
et
al
panel
recombin
virus
use
studi
includ
chimer
virus
contain
differ
laboratori
field
vaccin
strain
eav
chimer
viru
contain
ntermin
ectodomain
european
strain
prrsv
mutant
virus
singl
sitespecif
substitut
protein
neutral
phenotyp
recombin
chimericmut
strain
eav
determin
eavspecif
mab
polyclon
equin
antisera
compar
parent
virus
substitut
deriv
substitut
individu
amino
acid
within
ectodomain
usual
result
differ
neutral
phenotyp
recombin
virus
analog
differ
neutral
phenotyp
field
strain
eav
studi
unequivoc
confirm
ectodomain
contain
critic
determin
eav
neutral
individu
neutral
site
ad
conform
interact
interact
unglycosyl
membran
protein
like
critic
express
individu
epitop
neutral
conform
interestingli
overlap
neutral
virul
determin
locat
protein
eav
tabl
develop
infecti
cdna
clone
positivestrand
rna
virus
contemporari
molecular
biolog
techniqu
offer
new
approach
toward
ration
vaccin
design
construct
engin
defin
mutat
andor
delet
viru
genom
produc
attenu
minim
likelihood
revers
virul
de
vri
et
al
de
vri
et
al
obvious
substitut
delet
introduc
clone
viru
genom
must
hinder
recombin
viru
induc
protect
immun
vaccin
anim
castilloolivar
et
al
describ
gener
candid
live
marker
vaccin
eav
delet
major
neutral
domain
aa
protein
recombin
delet
mutant
viru
replic
normal
titer
cell
cultur
lower
rate
parent
viru
furthermor
two
poni
immun
delet
mutant
viru
remain
asymptomat
howev
viru
recov
nasal
secret
andor
blood
dpi
immun
poni
develop
weak
neutral
antibodi
respons
determin
serum
neutral
assay
use
viru
cvl
deriv
sequenti
passag
origin
vb
viru
contrast
viru
neutral
antibodi
respons
markedli
stronger
assay
sn
test
use
mutant
viru
immun
poni
protect
challeng
virul
laboratori
strain
eav
contrast
nonimmun
control
nasal
shed
viru
viremia
minim
transient
vaccin
author
conclud
immun
effector
mechan
viru
neutral
antibodi
must
exert
critic
role
protect
vaccin
poni
also
show
vaccin
poni
readili
could
distinguish
poni
infect
wild
type
viru
use
elisa
elisa
aa
describ
nugent
et
al
therefor
vaccin
hors
delet
mutant
marker
vaccin
potenti
facilit
serolog
discrimin
vaccin
natur
infect
hors
socal
diva
strategi
similarli
eav
cdna
clone
use
develop
disabl
infecti
singlecycl
disc
mutant
use
complement
cell
line
express
minor
structur
protein
formal
g
zevenhoven
dobb
et
al
howev
vaccin
base
recombin
dna
technolog
yet
adopt
field
use
equin
industri
stabl
fulllength
cdna
clone
mlv
vaccin
strain
eav
recent
develop
peavrmlv
zhang
et
al
recombin
viru
rmlv
nucleotid
ident
parent
mlv
vaccin
strain
eav
singl
silent
nucleotid
substitut
introduc
nucleocapsid
gene
peavrmlvb
enabl
clone
vaccin
viru
rmlvb
distinguish
parent
mlv
vaccin
well
field
laboratori
strain
eav
use
allel
discrimin
realtim
rtpcr
assay
vivo
studi
confirm
clone
vaccin
viru
safe
induc
high
titer
neutral
antibodi
eav
experiment
immun
hors
howev
challeng
heterolog
eav
strain
rmlvb
vaccin
viru
protect
immun
hors
reflect
reduc
magnitud
durat
viremia
viru
shed
balasuriya
et
al
c
zhang
et
al
vaccin
prevent
develop
sign
eva
although
reduc
clinic
sever
believ
one
known
serotyp
eav
field
strain
differ
neutral
phenotyp
balasuriya
et
al
balasuriya
et
al
balasuriya
et
al
maclachlan
balasuriya
miszczak
et
al
shown
previous
serum
hors
vaccin
mlv
vaccin
strain
neutral
eav
field
strain
rel
low
titer
r
balasuriya
et
al
balasuriya
et
al
zhang
et
al
may
explain
vaccin
hors
complet
protect
clinic
sign
eva
follow
challeng
heterolog
eav
strain
also
confirm
import
high
titer
neutral
antibodi
z
protect
clinic
sign
eav
infect
fukunaga
mccollum
timoney
et
al
recent
data
also
emphas
import
conduct
addit
indepth
crossneutr
perhap
vaccin
challeng
studi
use
recent
eav
isol
repres
three
phylogenet
clade
eav
north
american
two
european
infecti
cdna
clone
mlv
vaccin
strain
eav
provid
resourc
could
use
design
develop
broadli
protect
recombin
mlv
vaccin
systemat
incorpor
key
neutral
epitop
variou
eav
isol
significantli
distinct
neutral
phenotyp
furthermor
vaccin
clone
peavrmlvb
could
manipul
improv
vaccin
efficaci
well
develop
marker
vaccin
serolog
differenti
eav
natur
infect
vaccin
anim
diva
develop
revers
genet
manipul
sever
infecti
cdna
clone
wellcharacter
eav
strain
clearli
shown
multipl
viral
gene
involv
determin
viru
phenotyp
eg
virulenceattenu
viral
persist
cellular
tropism
neutral
studi
confirm
amino
acid
substitut
structur
nonstructur
protein
may
allow
field
strain
eav
evad
protect
host
immun
respons
facilit
persist
infect
stallion
importantli
differ
viral
phenotyp
typic
associ
singl
code
chang
specif
viral
gene
lead
singl
amino
acid
chang
rather
differ
phenotyp
involv
multipl
differ
chang
viral
gene
multigen
lead
emergenceselect
variant
divers
phenotyp
although
use
infecti
cdna
clone
deriv
virus
defin
phenotyp
allow
us
better
character
viral
determin
behavior
stress
nucleotid
amino
acid
chang
identifi
laboratori
strain
eav
may
ident
andor
contribut
phenotyp
chang
field
strain
viru
occur
natur
furthermor
import
emphas
perform
detail
biochem
function
analyz
identifi
effect
amino
acid
chang
specif
nsp
might
respons
attenuationvirul
phenotyp
eav
therefor
extrapol
find
laboratori
studi
identif
genet
determin
key
phenotyp
properti
eg
virul
persist
etc
field
strain
eav
done
cautious
lastli
stress
identif
critic
attenu
mutat
within
either
nonstructur
structur
viral
protein
provid
opportun
prospect
design
new
safe
efficaci
genet
engin
mlv
vaccin
eva
summari
select
care
analysi
genet
phenotyp
data
wellcharacter
eav
strain
includ
revers
genet
manipul
led
identif
appar
critic
determin
phenotyp
properti
viru
similar
approach
use
well
character
strain
respect
cdna
clone
arterivirus
prrsv
ldv
shfv
wpdv
also
facilit
studi
defin
molecular
basi
viral
virul
neutral
persist
cellular
tropism
